Pharmaceutical HIV prevention technologies in the UK: six domains for social science research

References

• Adam, B. (2005). Constructing the neoliberal sexual actor: Responsibility and care of the self in the discourse of barebackers. Culture, Health & Sexuality, 7, 333–346. doi:10.1080/13691050500100773
   PubMed Web of Science ®Google Scholar
• Adam, B. (2011). Epistemic fault lines in the biomedical and social approaches to HIV prevention. Journal of the International AIDS Society, 14(Suppl. 2), S2. doi:10.1057/palgrave.sth.8700066
   PubMedGoogle Scholar
• Adam, B., Maticka-Tyndale, J., & Cohen, J. (2003). Adherence practices among people living with HIV. AIDS Care: Psychological and Sociological Aspects of AIDS/HIV, 15, 263–274.
   PubMed Web of Science ®Google Scholar
• Adams, E., Ogden, D., Erlich, A., & Hay, P. (2013). Treatment for stable HIV patients in England: Can we increase efficiency and improve patient care? Journal of Health Services Research and Policy, 19(3), 131–137. doi:10.1177/1355819613508176
   PubMed Web of Science ®Google Scholar
• Aghaizu, A., Brown, A., Nardone, A., Gill, O., & Delpech, V. (2013). HIV in the United Kingdom 2013 report: Data to end 2012. London: Public Health England.
   Google Scholar
• Altman, D. (1994). Power and community: Organisation and cultural responses to AIDS. London: Taylor and Francis.
   Google Scholar
• Anderson, W. J., & Weatherburn, P. (2004). The needs of people with HIV in the UK: Findings from a national survey. International Journal of STD and AIDS, 15, 793–796. doi:10.1258/0956462042563602
   PubMed Web of Science ®Google Scholar
• Asboe, D., Aitken, C., Boffio, M., Booth, C., Cane, P., Fakoya, A., … BHIVA Guidelines Subcommittee. (2012). British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1 infected individuals in 2011. HIV Medicine, 13(1), 1–44. doi:10.1111/j.1468-1293.2011.00971.x
   PubMed Web of Science ®Google Scholar
• Baumgartner, L. M. (2007). The incorporation of the HIV/AIDS identity into the self over time. Qualitative Health Research, 17, 919–931. doi:10.1177/1049732307305881
   PubMed Web of Science ®Google Scholar
• Berridge, V. (1996). AIDS in the UK: The making of policy 1981–1994. Oxford: Oxford University Press.
   Google Scholar
• Bourne, A., Dodds, C., Keogh, P., Weatherburn, P., & Hammond, G. (2009). Relative safety II: Risk and unprotected anal intercourse among men with diagnosed HIV. London: Sigma Research.
   Google Scholar
• Bourne, A., Dodds, C., Weatherburn, P., & Keogh, P. (2011). Perceptions of superinfection risk among gay men with diagnosed HIV who have unprotected anal intercourse. International Journal of STD and AIDS, 22, 190–193. doi:10.1258/ijsa.2011.010116
   PubMed Web of Science ®Google Scholar
• Bourne, A., Dodds, C., Weatherburn, P., Madyara, A., Ntabyera, E., Owour, J., … Hammond, G. (2011). Plus one: HIV sero-discordant relationships among black African people in England. London: Sigma Research.
   Google Scholar
• Bourne, A., Hickson, F., Keogh, P., Reid, D., & Weatherburn, P. (2012). Problems with sex among gay and bisexual men with diagnosed HIV in the United Kingdom. BMC Public Health, 916, 1471–2458.
   Google Scholar
• Centers for Disease Control and Prevention. (2013). Update to interim guidance for Preexposure Prophylaxis (PrEP) for the prevention of HIV infection: PrEP for injecting drug users. Morbidity and Mortality Weekly, 62, 463–465.
   PubMed Web of Science ®Google Scholar
• Clarke, A., Mamo, L., Fosket, J., Fishman, J., & Shim, J. (2010). Biomedicalization: Technoscience, health, and illness in the U.S. Durham & London: Duke University Press.
   Google Scholar
• Cohen, M., Chen, Y., McCauley, M., Gamble, T., & Bollinger, R. (2011). Antiretroviral treatment to prevent the sexual transmission of HIV-1: Results from the HPTN 052 multinational randomized controlled trial. Rome: Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
   Google Scholar
• Cohen, M. S., Dye, C., Fraser, C., Miller, W. C., Powers, K. A., Williams, B. G., & Bartlett, J. (2012). HIV treatment as prevention debate and commentary – will early infection compromise treatment as prevention strategies. PLoS Medicine, 9(7), e1001232. doi:10.1371/journal.pmed.1001232.g001
   Google Scholar
• Davis, M., & Flowers, P. (2011). Love and HIV serodiscordance in gay men’s accounts of life with their regular partners. Culture, Health and Sexuality, 13, 737–749. doi:10.1080/13691058.2011.552986
   PubMed Web of Science ®Google Scholar
• Davis, M. D. M., Hart, G., Imrie, J., Davidson, O., Williams, I., & Stephenson, J. (2002).“HIV is HIV to me”: The meanings of treatment, viral load and reinfection for gay men living with HIV. Health Risk and Society, 4(1), 31–43. doi:10.1080/13698570210288
   Web of Science ®Google Scholar
• Davis, M., & Squire, C. (2010). HIV technologies in international perspective (1st ed.). London: Palgrave.
   Google Scholar
• Delpech, V. (2012, October 5). Treatment as prevention (TasP) in the UK: What are the challenges. BHIVA Autumn Conference, BHIVA, London.
   Google Scholar
• Department of Health. (2012). HIV treatment for overseas visitors: Guidance for the NHS. London: The Stationary Office.
   Google Scholar
• Doyal, L. (2013). Living with HIV and dying with AIDS: Diversity, inequality and human rights in the global pandemic (1st ed.). London: Ashgate.
   Google Scholar
• Epstein, S. (1998). Impure science: AIDS, activism and the politics of knowledge. Berkeley: University of California Press.
   Google Scholar
• European AIDS Treatment Group. (2014). Community consensus statement on the use of antiretroviral therapy in. Brussels: EAGA.
   Google Scholar
• Flowers, P. (2010). HIV transitions: Consequences for self in an era of medicalisation. In M. Davis & C. Squire (Eds.), HIV technologies in international perspective (pp. 109–126). London: Palgrave Macmillan.
   Google Scholar
• Flowers, P., Davis, M., Hart, G., Rosengarten, M., Frankis, J., & Imrie, J. (2006). Diagnosis and stigma and identity amongst HIV positive Black Africans living in the UK. Psychology & Health, 21(1), 109–122.
   Web of Science ®Google Scholar
• Flowers, P., Duncan, B., & Frankis, J. (2000). Community, responsibility and culpability: HIV risk‐management amongst Scottish gay men. Journal of Community & Applied Social Psychology, 10, 285–300. doi:10.1002/1099-1298(200007/08)10:4<285::AID-CASP584>3.0.CO;2-7
   Web of Science ®Google Scholar
• Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011). The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clinical Infectious Diseases, 52, 793–800. doi:10.1093/cid/ciq243
   PubMed Web of Science ®Google Scholar
• GNP+. (2012). GNP+ position paper: ART for prevention. Amsterdam: Author.
   Google Scholar
• Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A.Y., Vargas, L., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363, 2587–2599. doi:10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• Green, G., & Sobo, E. (2000). The endangered self: Managing the social risk of HIV (1st ed.). London: Routledge.
   Google Scholar
• Halkitis, P. N., Wilton, L., Wolitski, R. J., Parsons, J. T., Hoff, C. C., & Bimbi, D. S. (2005). Barebacking identity among HIV positive gay and bisexual men: Demographic, psychological and behavioural correlates. AIDS, 19(Suppl. 1), S27–S35. doi:10.1097/01.aids.0000167349.23374.a3
   PubMed Web of Science ®Google Scholar
• Havlir, D., & Beyrer, C. (2012). The beginning of the end of AIDS? New England Journal of Medicine, 367, 685–687. doi:10.1056/NEJMp1207138
   PubMed Web of Science ®Google Scholar
• Heywood, M. (2009). South Africa’s treatment action campaign: Combining law and social mobilization to realize the right to health. Journal of Human Rights Practice, 1(1), 14–36. doi:10.1093/jhuman/hun006
   Google Scholar
• Imrie, J., Elford, J., Kippax, S., & Hart, G. J. (2007). Biomedical HIV prevention—And social science. The Lancet, 370(9581), 10–11. doi:10.1016/S0140-6736(07)61026-5
   PubMed Web of Science ®Google Scholar
• International AIDS Alliance. (2012). Treatment as prevention: Making it work for communities most affected by HIV. Brighton: Author.
   Google Scholar
• James, R. (2011). Keep taking the tablets: HIV, rights and bio-activism in the post-ART era ( PhD thesis). University of London, Birkbeck.
   Google Scholar
• Keogh, P. (2008a). How to be a healthy homosexual: HIV health promotion and the social regulation of gay men in the UK. Journal of Homosexuality, 55, 581–605. doi:10.1080/00918360802421692
   PubMed Web of Science ®Google Scholar
• Keogh, P. (2008b). Morality, responsibility and risk: Negative gay men’s perceived proximity to HIV. AIDS Care, 20, 576–581. doi:10.1080/09540120701867123
   PubMed Web of Science ®Google Scholar
• Keogh, P. (2013). Austerity discourses and pharmaceutical HIV prevention technologies among people with HIV in London. Paris: Association for the Social Sciences and Humanities in HIV.
   Google Scholar
• Keogh, P., Weatherburn, P., & Stephens, M. (1999). Relative safety: Risk and unprotected anal intercourse among men diagnosed with HIV. London: Sigma Research.
   Google Scholar
• Kinsman, G. (1996). ‘Responsibility’ as a strategy of governance: Regulating people living with AIDS and lesbians and gay men in Ontario. Economy and Society, 25, 393–409. doi:10.1080/03085149600000021
   Web of Science ®Google Scholar
• Kippax, S., & Stephenson, N. (2012). Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health. American Journal of Public Health, 102, 789–799. doi:10.2105/AJPH.2011.300594
   PubMed Web of Science ®Google Scholar
• Klitzman, R., & Bayer, R. (2003). Moral secrets: Truth and lies in the age of AIDS. Baltimore, MD: Johns Hopkins University Press.
   Google Scholar
• Lupton, D. (1999). Risk. London: Routledge.
   Google Scholar
• Lupton, D., Mccarthy, S., & Chapman, S. (1995a). “Doing the right thing”: The symbolic meanings and experiences of having an HIV antibody test. Social Science and Medicine, 41, 173–180. doi:10.1016/0277-9536(94)00317-M
   PubMed Web of Science ®Google Scholar
• Lupton, D., Mccarthy, S., & Chapman, S. (1995b). “Panic bodies”: Discourses on risk and HIV antibody testing. Sociology of Health and Illness, 17(1), 89–108. doi:10.1111/1467-9566.ep10934489
   Web of Science ®Google Scholar
• Marks, G., & Crepaz, N. (2001). HIV-positive men’s sexual practices in the context of self-disclosure of HIV status. Journal of Acquired Immune Deficiency Syndrome, 27(1), 79–85. doi:10.1097/00126334-200105010-00013
   PubMed Web of Science ®Google Scholar
• Mayer, K. H. (2014). Antiretroviral chemoprophylaxis: State of evidence and the research agenda. Clinical Infectious Diseases, 59(Suppl. 1), S47–S51. doi:10.1093/cid/ciu322
   Google Scholar
• McCormack, S., Gafos, M., Desai, M., & Cohen, M. (2014). Biomedical prevention: State of the science. Clinical Infectious Diseases, 59(Suppl. 1), S41–S46. doi:10.1093/cid/ciu297
   Google Scholar
• Miller, W., Powers, K., Smith, M., & Cohen, M. (2013). Community viral load as a measure for assessment of HIV treatment as prevention. The Lancet Infectious Diseases, 13, 459–464. doi:10.1016/S1473-3099(12)70314-6
   PubMed Web of Science ®Google Scholar
• Moatti, J., Marlink, R., Luchini, S., & Kazatchkine, M. (2008). Universal access to HIV treatment in developing countries: Going beyond the misinterpretations of the “cost-effectiveness” algorithm. AIDS, 22(Suppl. 1), S59–S66. doi:10.1097/01.aids.0000327624.69974.41
   Google Scholar
• Mykhalovskiy, E., & Rosengarten, M. (2009). HIV/AIDS in its third decade; renewed critique in social and cultural analysis. Social Theory and Health, 7, 187–195. doi:10.1057/sth.2009.13
   Web of Science ®Google Scholar
• National AIDS Trust. (2012). How does the NHS buy HIV Drugs? Retrieved November 28, 2013, from http://www.nat.org.uk/media/Files/Policy/2012/April-2012-Briefing-drugs-prescribing.pdf
   Google Scholar
• Nguyen, V., Bajos, N., Dubois-Arberd, F., O’Malleye, J., & Pirklef, C. (2011). Remedicalizing an epidemic: From HIV treatment as prevention to treatment is prevention. AIDS, 25, 291–293. doi:10.1097/QAD.0b013e3283402c3e
   PubMed Web of Science ®Google Scholar
• Nguyen, V., Yapo Ako, C., & Niamba, P. (2007). Adherence as therapeutic citizenship: Impact of the history of access to antiretroviral drugs on adherence to treatment. AIDS, 21(Suppl. 5), S31–S35. doi:10.1097/01.aids.0000298100.48990.58
   PubMed Web of Science ®Google Scholar
• Nixon, S., Hanass-Hancock, J., Whiteside, A., & Barnett, T. (2011). The increasing chronicity of HIV in sub-Saharan Africa: Re-thinking “HIV as a long-wave event” in the era of widespread access to ART. Globalization and Health, 7(1), 41. doi:10.1186/1744-8603-7-41
   PubMed Web of Science ®Google Scholar
• Patton, C. (2011). Rights language and HIV treatment: Universal care or population control. Rhetoric Quarterly, 41, 250–266.
   Web of Science ®Google Scholar
• Persaud, D. (2013, March 3-6). Functional HIV cure after very early ART of an infected infant. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta.
   Google Scholar
• Persson, A. (2008). Sero-silence and sero-sharing: Managing HIV in serodiscordant heterosexual relationships. AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV, 20, 503–506. doi:10.1080/09540120701787487
   PubMed Web of Science ®Google Scholar
• Persson, A. (2012). Non/infectious corporealities: Tensions in the biomedical era of “HIV normalisation” Tensions in the biomedical era of “HIV normalisation”. Sociology of Health and Illness, 35, 1065–1079. doi:10.1111/1467-9566.12023
   PubMed Web of Science ®Google Scholar
• Persson, A. (2013, July 7–10). Selling TasP to serodiscordant couples: The perspective of HIV service providers. 2nd International Conference for the Social Sciences and Humanities in HIV, Paris.
   Google Scholar
• Piot, P., & Coll Seck, A. (2001). International response to the HIV/AIDS epidemic: Planning for success. Bulleting of the World Health Organisation, 79, 1106–1112.
   PubMed Web of Science ®Google Scholar
• Pollack, A., & McNeil, D. (2013, March 3). In medical first, a baby with HIV is deemed cured. New York Times. p. A1.
   Google Scholar
• Rosengarten, M. (2009). HIV interventions: Biomedicine and the traffic between information and flesh (1st ed.). Seattle: University of Washington Press.
   Google Scholar
• Rosengarten, M., Imrie, J., Flowers, P., Davis, M. D., & Hart, G. (2004). After the euphoria: HIV medical technologies from the perspective of their prescribers. Sociology of Health and Illness, 26, 575–596. doi:10.1111/j.0141-9889.2004.00406x
   PubMed Web of Science ®Google Scholar
• Seeley, J., Watts, C., Kippax, S., Russell, S., Heise, L., & Whiteside, A. (2012). Addressing the structural drivers of HIV: A luxury or necessity for programmes? Journal of the International AIDS Society, 15(Suppl. 1), 17397.
   PubMed Web of Science ®Google Scholar
• Squire, C. (2012). Being naturalised, being left behind: The HIV citizen in the era of treatment possibility. Critical Public Health, 20, 401–427.
   Web of Science ®Google Scholar
• The HIV Modelling Consortium Treatment as Prevention Editorial Writing Group. (2012). HIV treatment as prevention: Models, data, and questions – Towards evidence-based decision-making. PLoS Medicine, 9(7), e1001259. doi:10.1371/journal.pmed.1001259.g001
   Google Scholar
• US Food and Drug Administration. (2012, July 16). FDA approves first drug for reducing the risk of sexually acquired HIV infection. Press Release. Retrieved November 28, 2013, from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312210.htm
   Google Scholar
• Van de Ven, P., Kippax, S., Knox, S., Prestage, G., & Crawford, J. (1999). HIV treatment optimism and sexual behaviour among gay men in Sydney and Melbourne. AIDS, 13, 2289–2294. doi:10.1097/00002030-199911120-00011
   PubMed Web of Science ®Google Scholar
• Van Teijlingen, E., Pitchforth, E., Bishop, C., & Russell, E. (2006). Delphi method and nominal group technique in family planning and reproductive health research. Journal of Family Planning and Reproductive Health Care, 32, 249–252. doi:10.1783/147118906778586598
   PubMed Web of Science ®Google Scholar
• Vernazza, P. (2008). Les personnes séropositives ne souffrant d’aucune autre MST et suivant un traitment antirétroviral efficace ne transmettent pas le VIH par voie sexuelle [HIV-positive people who do not have any other STI receiving effective antiretroviral treatment do not transmit HIV through sex]. Bulletin des Médecins Suisses, 89(5), 23–28.
   Google Scholar
• Vernooji, E. (2013, July 7–10). Making it work: The role of the social sciences in a TasP implementation study. International Conference for the Social Sciences and Humanities in HIV, Paris.
   Google Scholar
• Williams, I. (2014). British HIV association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Medicine, 15(1), 1–85.
   Web of Science ®Google Scholar
• Williams, S., Gabe, J., & Davis, P. (2009). Pharmaceuticals and society: Critical discourses and debates (1st ed.). London: Wiley Blackwell.
   Google Scholar
• Wilson, D. (2012). HIV treatment as prevention: Natural experiments highlight limits of antiretroviral treatment as prevention. PLoS Medicine, 9(7), e1001231. doi:10.1371/journal.pmed.1001231.g002
   PubMed Web of Science ®Google Scholar
• Yeatman, A., & Dowsett, G. (2009). Service delivery and HIV-positive gay men: Pre and post advent of highly active antiretroviral treatment (HAART). In A. Yeatman, G. W. Dowsett, M. Fine, & D. Gursansky (Eds.), Individualisation and the delivery of welfare services: Contestation and complexity (pp. 187–209). Basingstoke: Palgrave Macmillan.
   Google Scholar
• Young, I., & McDaid, L. (2014). How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behaviour, 18, 195–216.
   PubMed Web of Science ®Google Scholar